In the Netherlands, Saxenda is now included in the basic health insurance package for the treatment of a limited number of people with serious obesity, defined as a BMI over 35
In conjunction with earnings, Amgen announced that it has completed an interim analysis of a phase 2 trial of obesity drug candidate maritide (AMG 133)
For those on GLP-1 therapy, especially older adults or individuals engaging in any form of resistance training, creatine may be a valuable addition to support healthy, sustainable weight loss
From identity shifts to emotional roadblocks, youll learn how to spot the psychological patterns behind common GLP-1 strugglesand how to support lasting change with empathy, validation, and connection
We start with comprehensive labs, a body composition scan, and a full intake before we prescribe anything
Under the Inflation Reduction Act, Medicare has gained the ability to negotiate prices for high-cost drugs